In the wake of Thermo Fisher Scientific, Inc.'s TMO impending acquisition of Affymetrix, Inc. AFFX, the latter has finally chosen to stick to Thermo Fisher's $1.3 billion takeover bid. With this ...
SANTA CLARA, Calif., May 10, 2010 (BUSINESS WIRE) -- Affymetrix, Inc. (NASDAQ: AFFX) today announced that it has delivered the first custom array designed for a 100,000-sample genotyping project to be ...
Affymetrix Inc. AFFX recently announced that it has entered into a strategic partnership with Cytox, a developer of assays for risk assessment and prediction of dementia. Under the terms of the deal, ...
(NASDAQ: AFFX) today announced the expansion of its license agreement with Siemens Healthcare Diagnostics for the company’s branched DNA (bDNA) technology whereby Affymetrix is the exclusive licensee ...
Mindy Lee-Olsen, 408-731-5523 (Media)Vice President, Marketing ServicesorDoug Farrell, 408-731-5285 (Investors)Vice President, Investor Relations (NASDAQ:AFFX) announced today the availability of ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (Nasdaq: AFFX) today announced that Dr. Frank Witney has been appointed president and chief executive officer, effective July 1, 2011. Dr. Witney ...
Affymetrix Inc. on Wednesday postponed a vote on its proposed tie-up with Thermo Fisher Scientific Inc.,TMO0.35%increase; up pointing triangle saying a new unsolicited bid from Origin Technologies ...
Affymetrix, Inc. and ScreenCell have announced the signing of a worldwide distribution agreement for ScreenCell’s isolation devices and dilution buffers, designed for the collection of Circulating ...
SAN DIEGO & SANTA CLARA, Calif., Jan 10, 2008 - Affymetrix and Illumina, Inc. (NASDAQ:ILMN) announced today that they have entered into a settlement agreement to resolve their patent litigation. Under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results